Heart Failure Monitoring Tech Doubles Sensitivity for Predicting Events Versus Standard of Care
Bodyport says its biomarker-based technology for remote heart failure monitoring detected twice as many heart failure events.
Bodyport says its biomarker-based technology for remote heart failure monitoring detected twice as many heart failure events.
Researchers discovered a way to track levels of omega-3 fatty acids in the bloodstream to gain information critical to cardiovascular health.
A simple blood test may predict the risk of progressive heart and kidney disease in people with Type 2 diabetes and kidney disease.
The new CONNEQT Pulse is a customizable vascular biometric monitor that provides medical grade arterial heart health metrics.
Read MoreIllumina and Henry Ford Health launched a partnership to assess the impact of comprehensive genomic testing in cardiovascular disease.
Read MoreBio-Rad has launched its newest cardiac control product, Cardiac Advance, to monitor the precision of instrument testing for cardiac events.
Read MoreA new proteomic risk model for cardiovascular disease was found to be more accurate than current methods of measuring cardiac risk
Read MoreEko, a digital health company applying AI to address heart and lung disease, has launched the SENSORA Cardiac Disease Detection Platform.
Read MoreProterixBio’s ST2 Assay is for use in conjunction with clinical evaluation in assessing the prognosis of patients with chronic heart failure.
Read MoreCareDx announced the publication of International Society for Heart and Lung Transplantation guidelines supporting its surveillance portfolio.
Read MoreMade of graphene, the device is worn on the wrist and can measure blood pressure with comparable accuracy to a standard blood pressure cuff.
Read MoreResearchers devised a new biomarker-based strategy to screen for a deadly complication caused by monoclonal antibodies used to treat cancer.
Read MoreNeuome Peptides Pte. established an assay-development platform for the quantifiable detection of biomarkers.
Read MoreThe method uses molecular profiling and AI to develop dietary signatures to predict cardiovascular disease and type 2 diabetes risks.
Read MoreHigh-density lipoprotein cholesterol may not be as effective as scientists once believed in predicting cardiovascular disease risks.
Read MoreClinicians who were high adopters of AI-enabled clinical decision support tools efficiently diagnosed low left ventricular ejection fraction.
Read MoreBlood sample tests for cardiac troponins are an important cornerstone in the diagnostics of heart attack. A new test improves their efficacy.
Read MoreVivid Microscopy’s high content screening probe tech was successful in a study on coronary microvascular disease in post-menopausal women.
Read More